ArticleESMO gastrointestinal oncology2024

Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to

E B Faber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.